bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.5 Billion EUR | -2.37% |
| 2022 | 1.54 Billion EUR | 7.04% |
| 2021 | 1.44 Billion EUR | -0.3% |
| 2020 | 1.44 Billion EUR | -5.29% |
| 2019 | 1.52 Billion EUR | 10.17% |
| 2018 | 1.38 Billion EUR | 10.61% |
| 2017 | 1.25 Billion EUR | -10.96% |
| 2016 | 1.4 Billion EUR | 10.74% |
| 2015 | 1.27 Billion EUR | 6.65% |
| 2014 | 1.19 Billion EUR | 28.25% |
| 2013 | 929.3 Million EUR | 46.81% |
| 2012 | 633 Million EUR | -3.92% |
| 2011 | 658.8 Million EUR | 39.4% |
| 2010 | 472.6 Million EUR | 4.26% |
| 2009 | 453.3 Million EUR | -9.48% |
| 2008 | 500.8 Million EUR | 26.11% |
| 2007 | 397.1 Million EUR | 3.93% |
| 2006 | 382.1 Million EUR | -6.26% |
| 2005 | 407.6 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.43 Billion EUR | -4.52% |
| 2023 Q2 | 1.38 Billion EUR | -10.0% |
| 2023 FY | 1.5 Billion EUR | -2.37% |
| 2023 Q4 | 1.5 Billion EUR | 8.47% |
| 2022 Q4 | 1.54 Billion EUR | 1.07% |
| 2022 FY | 1.54 Billion EUR | 7.04% |
| 2022 Q2 | 1.52 Billion EUR | 5.9% |
| 2021 Q4 | 1.44 Billion EUR | 2.41% |
| 2021 FY | 1.44 Billion EUR | -0.3% |
| 2021 Q2 | 1.4 Billion EUR | -2.65% |
| 2020 Q2 | 1.72 Billion EUR | 12.7% |
| 2020 Q4 | 1.44 Billion EUR | -15.96% |
| 2020 FY | 1.44 Billion EUR | -5.29% |
| 2019 Q4 | 1.52 Billion EUR | -0.17% |
| 2019 FY | 1.52 Billion EUR | 10.17% |
| 2019 Q2 | 1.52 Billion EUR | 10.36% |
| 2018 Q4 | 1.38 Billion EUR | 18.59% |
| 2018 FY | 1.38 Billion EUR | 10.61% |
| 2018 Q2 | 1.16 Billion EUR | -6.73% |
| 2017 Q2 | 1.28 Billion EUR | -8.82% |
| 2017 FY | 1.25 Billion EUR | -10.96% |
| 2017 Q4 | 1.25 Billion EUR | -2.35% |
| 2016 FY | 1.4 Billion EUR | 10.74% |
| 2016 Q2 | 1.24 Billion EUR | -1.8% |
| 2016 Q4 | 1.4 Billion EUR | 12.77% |
| 2015 FY | 1.27 Billion EUR | 6.65% |
| 2015 Q4 | 1.27 Billion EUR | 3.12% |
| 2015 Q2 | 1.23 Billion EUR | 3.42% |
| 2014 Q2 | 1.05 Billion EUR | 13.45% |
| 2014 Q4 | 1.19 Billion EUR | 13.04% |
| 2014 FY | 1.19 Billion EUR | 28.25% |
| 2013 Q2 | 635.4 Million EUR | 0.38% |
| 2013 Q4 | 929.3 Million EUR | 46.25% |
| 2013 FY | 929.3 Million EUR | 46.81% |
| 2012 Q2 | 649.7 Million EUR | -1.38% |
| 2012 FY | 633 Million EUR | -3.92% |
| 2012 Q4 | 633 Million EUR | -2.57% |
| 2011 Q2 | 481.4 Million EUR | 1.86% |
| 2011 FY | 658.8 Million EUR | 39.4% |
| 2011 Q4 | 658.8 Million EUR | 36.85% |
| 2010 Q4 | 472.6 Million EUR | -0.63% |
| 2010 FY | 472.6 Million EUR | 4.26% |
| 2010 Q2 | 475.6 Million EUR | 4.92% |
| 2009 FY | 453.3 Million EUR | -9.48% |
| 2009 Q4 | 453.3 Million EUR | 0.0% |
| 2008 FY | 500.8 Million EUR | 26.11% |
| 2007 FY | 397.1 Million EUR | 3.93% |
| 2006 FY | 382.1 Million EUR | -6.26% |
| 2005 FY | 407.6 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -41671.064% |
| Arrayit Corporation | 7.49 Million USD | -20003.799% |
| Atlantic International Corp. | 3.82 Million USD | -39264.073% |
| Biocept, Inc. | 22.01 Million USD | -6746.409% |
| Bioqual, Inc. | 18.93 Million USD | -7858.078% |
| CardioGenics Holdings Inc | 1.79 Million USD | -83864.605% |
| DermTech, Inc. | 64.75 Million USD | -2227.388% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -105.055% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -12067.811% |
| iMD Companies, Inc. | 1.67 Million USD | -89918.253% |
| IDenta Corp. | 1.01 Million USD | -148652.712% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -5252.488% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -505728.218% |
| InVitro International | 78.99 Thousand USD | -1907863.033% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -7539.009% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -1165510.958% |
| Medical Imaging Corp. | 9.51 Million USD | -15735.73% |
| NovelStem International Corp. | 4.2 Million USD | -35731.472% |
| Optigenex Inc. | 9.57 Million USD | -15647.153% |
| PharmChem, Inc. | 558.64 Thousand USD | -269676.8% |
| Proteome Sciences plc | 18.48 Million USD | -8051.31% |
| Response Genetics, Inc | 15.86 Million USD | -9398.33% |
| Rennova Health, Inc. | 49.66 Million USD | -2934.388% |
| RushNet, Inc. | 6.23 Million USD | -24056.146% |
| ScreenPro Security Inc. | 1.6 Million USD | -94059.205% |
| Stella Diagnostics Inc. | 18 Million USD | -8270.264% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -18270.332% |
| Todos Medical Ltd. | 50.15 Million USD | -2904.765% |